Skip to main content

LSL PHARMA GROUP ANNOUNCES APPOINTMENTS TO ITS BOARD OF DIRECTORS

Newswire.ca - Thu Oct 16, 2025

BOUCHERVILLE, QC, Oct. 16, 2025 /CNW/ - LSL PHARMA GROUP INC. (TSXV: LSL) (the "Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, today announced the appointment of Mr. Louis Laflamme as chairman of the board of directors and the appointment of Mr. Noureddine Mokaddem as a new member of the board of directors.

Read more at newswire.ca

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.